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Abstract Objective The objective of this study is to assess whether the largest cyst diameter is
useful for BI-RADS ultrasonography classification of predominantly solid breast masses
with an oval shape, circumscribed margins, and largest axis parallel to the skin, which,
except for the cystic component, would be likely classified as benign.
Methods This study received approval from the local institutional review board. From
March 2009 to August 2014, we prospectively biopsied 170 breast masses from 164
women. We grouped the largest cyst and mass diameters according to histopatholog-
ical diagnoses. We used Student’s t-test, linear regression, and the area under the
receiver operating characteristic curve (AUC) for statistical assessment.
Results Histopathological examination revealed 143 (84%) benign and 27 (16%)malignant
masses. The mean largest mass diameter was larger among malignant (mean  standard
deviation, 34.1  16.6 mm) than benignmasses (24.7  16.7 mm) (P < 0.008). The mean
largest cyst diameter was also larger amongmalignant (9.9  7.1 mm) than benignmasses
(4.6  3.6 mm) (P < 0.001). Agreement between measurements of the largest mass and
cyst diameters was low (R2 ¼ 0.26). AUC for the largest cyst diameter (0.78) was similar to
the AUC for the largest mass diameter (0.69) (p ¼ 0.2). A largest cyst diameter < 3,  3
to < 11, and  11 mm had a positive predictive value of 0, 15, and 52%, respectively.
Conclusion A largest cystic component < 3 mm identified within breast masses that
show favorable characteristics may be considered clinically inconsequential in ultrasonog-
raphy characterization. Conversely, masses with a largest cystic component  3 mm
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Breast lesions may be sonographically characterized with
the Breast Imaging Reporting and Data System (BI-RADS-
US) according to the malignancy risk.1–3 Breast masses with
solid and cystic echo pattern should be described as com-
plex solid and cystic and classified as BI-RADS-US category
4.3–9 In this category, the risk of malignancy is > 2% to
 95% and such lesions should be investigated by biopsy.3–9
In contrast, breast masses with an oval shape, circum-
scribed margins, orientation parallel to the skin, and hypo-
echoic echo pattern are coded as probably benign and
classified as BI-RADS-US category 3.3,10 The risk of malig-
nancy in this category is < 2%, and biopsy may be avoided if
the mass maintains the same morphology and stable di-
mensions during follow-up.3,10 Therefore, sonographic
identification of a cyst or several cysts within a predomi-
nantly solid breast mass, in which the other morphologic
features are consistent with BI-RADS-US category 3, still
justifies a description of the mass as complex. Hence, a
predominantly solid mass with an oval shape, circum-
scribed margins, and largest axis parallel to the skin should
be classified as BI-RADS-US category 4.11 However, recom-
mending biopsy may seem exaggerated in such cases,
particularly if there is only one discrete cystic focus.11
This issue led us to carry out a prospective study of
predominantly solid breast masses with an oval shape,
circumscribed margins, and largest axis parallel to the
skin, which, except for the cystic component, would other-
wise be classified as probably benign. A previous pilot study
presented the results of a sample of 48 breast masses. These
masses accounted for 3% of breast ultrasound studies in a
breast imaging section located in a reference university
hospital for breast cancer treatment.11 The prevalence of
malignancy in that sample was 25%, confirming that such
masses should be described as BI-RADS-US category 4.
Moreover, the largest cyst diameter of eachmass was signifi-
cantly related to the histopathological diagnosis of malig-
nancy. All masses with a largest cyst diameter < 3 mmwere
benign, and all masseswith a largest cyst diameter > 13 mm
were malignant.11
The purpose of the current study was to assess whether
the largest cyst diameter is a useful ultrasonography variable
for BI-RADS-US classification of predominantly solid breast
masses with an oval shape, circumscribed margins, and
largest axis parallel to the skin, which, except for the cystic
Resumo Objetivo Avaliar se o maior diâmetro do cisto é útil para a classificação ultrassono-
gráfica BI-RADS de nódulos mamários predominantemente sólidos, com forma oval,
margens circunscritas e maior eixo paralelo à pele que, exceto pela presença do
componente cístico, seriam classificados como provavelmente benignos.
Métodos Este estudo foi aprovado pelo Comitê de Ética local. De março de 2009 a
agosto de 2014, 170 nódulos mamários de 164 mulheres foram prospectivamente
biópsiados. As medidas do maior diâmetro do maior cisto e do maior diâmetro do
nódulo foram agrupados de acordo com os diagnósticos histopatológicos. O teste t de
Student, a regressão linear e a área sob a curva ROC (AUC) foram utilizados para a
avaliação estatística.
Resultados O exame histopatológico revelou 143 (84%) nódulos benignos e 27
(16%) nódulos malignos. A média da medida do maior diâmetro dos nódulos foi
maior entre os nódulos malignos (média  desvio padrão, 34,1  16,6 mm) do que
nos nódulos benignos (24,7  16,7 mm) (p < 0,008). A média do maior diâmetro do
maior cisto também foi maior entre os nódulos malignos (9,9  7,1 mm) do que nos
nódulos benignos (4,6  3,6 mm) (p < 0,001). A concordância entre as medidas dos
maiores diâmetros dos nódulos e do maior diâmetro do maior cisto foi baixa
(R2 ¼ 0,26). A AUC do maior diâmetro do maior cisto (0,78) foi semelhante à
AUC do maior diâmetro do nódulo (0,69) (p ¼ 0,2). Os maiores diâmetros dos
maiores cistos medindo < 3;  3 e < 11; e  11 mm tiveram um valor preditivo
positivo de 0, 15 e 52%, respectivamente.
Conclusão Componentes císticos < 3 mm identificados dentro de nódulos mamá-
rios que apresentam as demais características provavelmente benignas podem ser
considerados clinicamente irrelevantes na caracterização ultrassonográfica. Por outro
lado, nódulos que apresentam um componente cístico medindo  3 mm devem ser
classificadas na categoria BI-RADS-US 4.
Palavras-chave







Rev Bras Ginecol Obstet Vol. 38 No. 4/2016
Cysts within Otherwise Probably Benign Solid Breast Masses and the Risk of Malignancy Jales et al. 171
component, would otherwise be classified as probably
benign.
Methods
This cross-sectional study with prospective collection data
was approved by our Institutional Review Board under
number 031/2009. All participants signed an informed con-
sent term. The research was performed according to the
Declaration of Helsinki, which was reviewed in 2008.
In a previous pilot study published in 2012, we presented
the results of 48 breast masses.11 This prior article suggested
that the largest cyst diameter of each mass was significantly
related to the histopathological diagnoses of malignancy. In
this article, we report this finding in a more representative
sample of 170 masses and assess the association between
largest cyst diameter and largest mass diameter.
Among all women who underwent breast ultrasound, we
selected those with predominantly solid breast masses with
an oval shape, circumscribed margins, and largest axis
parallel to the skin, which, except for the cystic component,
would otherwise be classified as probably benign. The medi-
cal indications for the examinations were sonographic eval-
uation of masses categorized as BI-RADS-MG category 0,
sonographic follow-up of breast masses previously coded as
BI-RADS-US category 3, sonographic screening in high-risk
patients with mammographically dense breasts, and sono-
graphic assessment of palpable breast masses.
In total, 170 masses from 164 women were included in
this study. Prior mammograms were available for 95/170
(56%) of the breast masses. Most women undergoing mam-
mography (70/95; 74%) were categorized as having BI-RADS
category 0 masses because of circumscribed/obscured mass
margins or focal asymmetry. In 20/95 (21%) women, the
mammogram was negative (BI-RADS-MG category 1 or 2).
Only 3/95 (3%) mammograms identified suspicious lesions
(BI-RADS-US-MG category 4), including microlobulated
margins (2 masses) or architectural distortion (1 mass).
All ultrasonographic examinations were performed from
March 2009 to August 2014 by the same clinician (R.M.J.)
with 12 years of experience in breast imaging. No patient
thatmet the ultrasonographic criteriawas excluded from the
study. The Voluson 730 Expert (GE Healthcare, Little Chal-
font, Buckinghamshire, United Kingdom) and Accuvix V10
(Medison Co., Ltd., Seoul, Korea) ultrasound machines were
the diagnostic equipment used.
We assessed predominantly solid breast masses with an
oval shape, circumscribedmargins, and largest axis parallel to
the skin, which except for the cystic component would
Fig. 1 First illustrative example of a mass in this study. There were
two cystic foci that alone or combined did not occupy more than half
of the mass. (A) The largest cystic diameter of the largest cyst
measured 13 mm. (B) The largest mass diameter measured 49 mm. In
our routine breast ultrasound practice, this mass would be described
as complex solid and cystic, classified as BI-RADS-US category 4, and
biopsied. This patient was 28 years old, and the mass was palpable.
Pathological analysis confirmed pseudoangiomatous stromal
hyperplasia.
Fig. 2 Second illustrative exampleof amass in this study.Onlyonediscreet
cystic focus was present. (A) The largest cystic diameter measured 2 mm.
(B) The largest mass diameter measured 31 mm. In our routine breast
ultrasound practice, this mass would be described as complex solid and
cystic, classified as BI-RADS-US category 4, and biopsied. The patient was
47 years old, and the mass was not palpable. Pathological analysis
confirmed a complex fibroadenoma. In this study, we demonstrated that a
largest cystic component < 3 mm may be ignored in the description and
characterization of breast masses.
Fig. 3 Third illustrative example of a mass in this study. There were
several cystic foci that alone or combined did not occupy more than
half of the mass. The largest cyst diameter measured 9 mm. The
largest mass diameter measured 49 mm. In our routine breast
ultrasound practice, this mass would be described as complex solid
and cystic, classified as BI-RADS-US category 4, and biopsied. The
patient was 52 years old, and the mass was palpable. Pathological
analysis confirmed a carcinosarcoma.
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otherwisebe classified as probably benign.We included in our
sample only masses in which the largest cystic component
measured  2 mm because cystic foci < 2 mm may not be
properly characterized by ultrasound. The cystic focus or foci
did not occupy more than half of the breast mass, and
the masses were therefore characterized as predominantly
solid. In breast masses with more than one cystic focus, only
the largest focus was measured and considered for
analysis.►Figs. 1 to 3 show examples of these breast masses.
In our routine breast ultrasound practice, these masses are
described as complex solid and cystic, classified as BI-RADS-
US category 4, and biopsied.11
We performed histopathological assessment of the ma-
jority of themasses (157/170; 92% of lesions) by ultrasound-
guided core needle biopsy using an automated biopsy gun
with a 14-gauge needle (Magnum; Bard Biopsy Systems,
Tempe, AZ). In 33/157 (21%) of the masses initially evaluated
by core needle biopsy, analysis was supplemented by exci-
sional biopsy. In 13/170 (8%) of the cases, we directly
evaluated the lesions by excisional biopsy.
Statistical Analysis
We included age,menstrual status, and physical examination
findings of the breasts as control variables. Ultrasound
variables assessed in the masses were the largest mass
diameter and the largest cyst diameter, both in millimeters
(►Fig. 1). We used a two-sample Student’s t-test or a chi-
squared test to compare data according to the benign or
malignant histopathological diagnosis.
The association between the largest cyst diameter and
largest mass diameter was evaluated by linear regression,
including measurement of correlation coefficient (R2) and
analysis of a scatterplot graph. The R2 is a numerical measure
of the strength of the relationship between two quantitative
variables.
The performance of the largest cyst diameter and largest
mass diameter in terms of malignancy prediction were
calculated by the area under the receiver operating char-
acteristic (ROC) curve. Through the coordinates of the ROC
curve, we selected ranges of the largest cyst diameter
measures related to the positive predictive values (PPVs)
suitable for BI-RADS categories. We also drew a pairwise
comparison of the areas under the ROC curve (AUC) for
these variables using Venkatraman’s projection-permuta-
tion test, using the software R Environment for Statistical
Computing (R Project).12Weperformed all other statistical
calculations with SPSS software version 15 (SPSS Inc.,
Chicago, IL). A P value < 0.05 was considered as indicating
a significant difference.
Results
In total, 170 breast masses from 164 women were available for
analysis. Histopathological examination revealed 143/170 (84%)
benign and 27/170 (16%) malignant pathological diagnoses.
These masses had a high prevalence of complex fibroadenomas
(36/143, 25%) and benign phyllodes tumors (7/143, 5%), but the
major benign pathological diagnosis was simplex fibroadenoma
(53/143, 37%). In contrast, the most frequent malignant patho-
logical diagnoses were invasive ductal carcinoma (15/27, 55%)
and mucinous carcinoma (4/27, 15%) (►Table 1).
Women presenting with malignant histopathological find-
ings were older (mean  standard deviation, 55.1  18.2
years; range, 32–77 years) than women with benign results
(39.5  11.6 years; range, 14–66 years) (P < 0.001). Malig-
nancy rates were higher for postmenopausal women (15/39,
38%) than for premenopausal women (12/131, 9%)
(P < 0.001). Palpablemasses weremore frequentlymalignant
(22/112, 19.6%) than were nonpalpable masses (5/58, 8.6%)
(p ¼ 0.046) (►Table 2).
The largest mass diameter was larger inmalignant masses
(34.1  16.6 mm; range, 11–66 mm) than in benign masses
(24.7  16.7 mm; range, 8–135mm) (p ¼ 0.008). The largest
cyst diameter was also larger in malignant masses
(9.9  7.1; range, 3–31 mm) than in benign masses
(4.6  3.6 mm; range, 2–25 mm) (P < 0.001) (►Table 3).
The scattergraph calculated by linear regression indicated
that there was a positive relationship between the largest
Table 1 Pathological diagnosis
Benign N (%) Malignant N (%)
Fibroadenoma 94 (65.5) Invasive ductal carcinoma 15 (55)
Simplex fibroadenoma 53 (37) Mucinous carcinoma 4 (15)
Complex fibroadenoma 36 (25) Papilliferous carcinoma 2 (7.5)
Hyalinized fibroadenoma 5 (3.5) Malignant Phyllodes tumor 1 (3.7)
Benign Phyllodes tumor 7 (5) In situ ductal carcinoma 1 (3.7)
PASH 7 (5) Medullar carcinoma 1 (3.7)
Apocrine metaplasia 5 (3.5) Carcinosarcoma 1 (3.7)
Lactating adenoma 4 (4) Lymphoma 1 (3.7)
Other benign diagnosis 26 (17) Metaplastic carcinoma 1 (3.7)
Total 143 (100) Total 27 (100)
Abbreviation: PASH, pseudoangiomatous stromal hyperplasia.
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cyst diameter and largest mass diameter. However, agree-
ment between measurements of these variables was low
(R2 ¼ 0.26) (►Fig. 4).
The AUC for the largest cyst diameter was similar to that
for the largest mass diameter (0.78 and 0.69, respectively;
p ¼ 0.2). The AUC for the largest cyst diameter was also
similar (0.73) when only considering women < 40 years old,
regardless of their clinical breast examination findings and
women  40 years of age presenting with nonpalpable
breast masses. Palpable breast masses in  40-year-old
women could be considered BI-RADS-US category 4, regard-
less of the cystic foci. Among all women, a largest cyst
diameter < 3,  3 to < 11, and  11 mm had a PPV of 0%,
15%, and 52%, respectively (►Fig. 5). These values are con-
sistent with BI-RADS-US categories 3, 4b, and 4c,
respectively.
Discussion
In this study, we demonstrated that the largest cyst diameter
was useful for BI-RADS ultrasonography classification of
predominantly solid breast masses with an oval shape,
circumscribed margins, and largest axis parallel to the
skin, which, except for the cystic component, would other-
wise be classified as probably benign. The performance of the
largest cyst diameter for malignancy prediction was main-
tained regardless of whether the clinical breast examination
findings were considered.
Although the largest cyst diameter tended to be larger in
larger breast masses, the majority of cases plotted in the
graph did not demonstrate this trend (R2 ¼ 0.26). Measure-
ment of the largest mass dimension is performed in routine
practice during breast imaging studies.12 The low





Largest mass diameter (mm) 24.7/16.7/8–135 34.1/16.6/11–66 0.008
Largest cystic diameter (mm) 4.6/3.6/2–25 9.9/7.1/3–31 < 0.0001
N N PPV (%)
Largest cystic diameter < 3 mm 43 0 0/43 (0)
Largest cystic diameter  3 mm and < 11 mm 90 16 16/106 (15)
Largest cystic diameter  11 mm 10 11 11/21 (52)
Total 143 (100) 27 (100)
Abbreviations: PPV, positive predictive value; SD, standard deviation.
Student’s t-test.
Table 2 Distribution of control variables according to the final pathological diagnosis
Pathological diagnosis
Variables Benign Malignant P
Mean/SD/Range Mean/SD/Range
Age 39.5 /11.6/14–66 55.1/18.2/32–77 < 0.001
N (%) N (%) Total
Menopause < 0.001#
Yes 24 (16.8) 15 (55.6) 39
No 119 (83.2) 12 (44.4) 131
Total 143 (100) 27 (100) 170
Palpable lesion 0.046#
Yes 90 (62.9) 22 (81.5) 112
No 53 (34.1) 5 (18.5) 58
Total 143 (100) 27 (100) 170
Abbreviation: SD, standard deviation.
Student’s t-test. #chi-squared test.
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concordance rate between the largest mass dimension and
the largest cyst dimension may justify including this mea-
surement in the ultrasonographyevaluation of complex solid
and cystic masses, which, except for the presence of a cystic
focus, would otherwise be classified as BI-RADS 3.
Another important contribution of our study was the
determination of the prevalence of malignancy in predomi-
nantly solid breast masses with an oval shape, circumscribed
margins, and largest axis parallel to the skin, which, except
for the cystic component, would otherwise be classified as
probably benign. The prevalence ofmalignancy in themasses
included in the current study (16%) was lower than that in a
previous pilot study (25%).11 This can be explained by the fact
that the current sample had a higher rate of masses in which
the cystic foci measured < 3 mm. Thus, the prevalence of
16% for the total sample is slightly lower than the rate
described for complex masses (23–31%), but it is still relates
to BI-RADS category 4.3,13
With respect to the histopathological results of the breast
masses studied, most masses had a histopathological result
of fibroadenoma (94/170 masses). Many these fibroadeno-
mas were classified as complex (36/94; 38% of benign
masses). The expected prevalence rate of complex fibroade-
nomas is lower, ranging from 16% to 22% in proven fibroa-
denomas.14,15 The high prevalence of complex
fibroadenomas in our sample was not surprising because
the presence of simple cysts > 3 mmwithin fibroadenomas
is one histopathological criterion that defines complex fi-
broadenoma. The remaining criteria include sclerosing ad-
enosis, epithelial calcifications, and papillary apocrine
changes.15
The significance of complex fibroadenoma is that women
presenting with these lesions have a 3.1-fold higher relative
risk of developing breast cancer compared with the general
population.15 The findings of the current study suggest that
the presence of small cystswithin circumscribedmassesmay
be related to complex fibroadenomas.
Another relevant factor in the analysis of the benign
histologic results was the prevalence of benign phyllodes
tumors. These tumors comprised 7/170 (4.0%) of the total
sample and 7/105 (6.7%) of fibroepithelial neoplasms. These
rates are higher than twice the expected rate of benign
Fig. 5 Receiver operating characteristics curves. ROC 1: Complete sample, regardless of age and clinical breast examination findings (170
masses). Area under the curve (AUC) for largest cyst diameter ¼ 0.78, and AUC for largest mass diameter ¼ 0.69. ROC 2: Sample limited
to < 40-year-old women regardless of clinical breast examination findings and  40-year-old women with nonpalpable breast masses (122
masses). AUC for largest cystic diameter ¼ 0.73.
Fig. 4 Scatterplot graph calculated by linear regression. There was a
positive relationship between the largest cyst diameter and largest
mass diameter. However, agreement between measurements of
these variables was low (R2 ¼ 0.26).
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phyllodes tumors, which account for < 1% of all breast
tumors and < 3% of fibroepithelial breast lesions.16 Phyllo-
des tumors are associated with a risk of recurrence and
distant metastases.17 Preoperative identification of phyllo-
des tumors is crucial for appropriate surgical planning and
prevention of surgical complications resulting from inade-
quate excision. Mammography and ultrasound examination
cannot adequately distinguish between fibroadenomas and
phyllodes tumors.18 The presence of a cystic foci has been
described as important in the diagnosis of this type of
tumor.19–22 Most of the masses in the present study had
histopathological results consistent with fibroadenomas, not
phyllodes tumors. Conversely, the size of the largest cystic
component may prove useful in identifying malignant phyll-
odes tumors.
The strengths of our study are its large sample size, which
required over four years of data gathering in a breast imaging
reference center; the homogeneous sample of patients, all of
whomwereselectedbyasingleexperiencedobserver;and,most
importantly, its conclusion is easily applicable in patient care.
A limitation of our study was our failure to clarify the
precise histopathology of the cystic foci. Nevertheless, we
can assume that the cystic foci in the four cases diagnosed as
mucinous carcinoma represented mucin. Furthermore, in
the remaining malignant histologic types included in our
sample, the cystic foci seen on ultrasonographywere likely to
correspond to small areas of necrosis associated with ineffi-
cient vascularity related to rapid tumor growth. Our sample
was restricted to circumscribed masses, which are usually
related to rapidly growing lesions.23–25
In conclusion, a largest cystic component < 3 mm identi-
fiedwithin breastmasses that show favorable characteristics
may be considered clinically inconsequential. Conversely,
masses with a largest cystic component  3 mm should be
classified as BI-RADS-US category 4 and biopsied.
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